INTRODUCTION
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is due to elevated secretion of antidiuretic hormone (ADH) in spite of blood hypoosmosis and extracellular fluid volume expansion. Its severe form is not common in neonates, although the diagnostic criteria for older children and adults cannot be directly applied to neonates, because of the low capacity of renal concentration in the neonatal period. 1, 2 However, clinically apparent SIADH is a matter of concern in relation to management of asphyxia, intracranial hemorrhage, pulmonary disease, pneumothorax, and positive pressure ventilation. Hyponatremia, a major symptom of SIADH, causes seizures when severe, requiring immediate treatment. Conventional treatment of SIADH mainly consists of restriction of water and salt as well as administration of diuretics. 2, 3 There are some reports of the use of phenytoin, which has a suppressive effect on ADH secretion, but no report of its use in the neonatal period. 4 -9 We report a recent case of a neonate in whom phenytoin was effective against SIADH and hyponatremic seizures caused by administration of anticancer drugs for an intracranial tumor.
CASE REPORT
The mother was 26 years old, with her first pregnancy. An infant girl was born at 39 weeks and 4 days of gestation, with a birth weight of 2682 g. Apgar scores were 10 at both 1 and 5 min. She was delivered with a normal presentation. Cyanosis was observed several hours following birth, and the infant was admitted for possible choanal atresia. Routine blood analysis, plain chest X-ray film, and cardiac, head, and abdominal ultrasonography showed no particular abnormality. A tumor accompanied by bone damage in and around the left orbit was found on cranial CT and MRI, and rhabdomyosarcoma was suspected histopathologically from needle biopsy at 7 days of age. Di mercapto succinic acid (DMS) tumor scintigraphy, bone marrow biopsy, and examination of spinal fluid showed no metastasis to other sites. Upon the diagnosis of grade 3 rhabdomyosarcoma, treatment [vincristine (1 mg/m 2 ), adriamycin (15 mg/m 2 ), cyclophosphamide (4.8 mg/m 2 ), cisplatin (47 mg/m
2 ) ] was started at 14 days of age. To alleviate renal damage from cisplatin, total fluid administration (oral milk and maintenance fluid) was increased to 180 ml/kg/d. On the eighth day after the start of treatment, she developed hyponatremia along with tonic-clonic seizures. Calcium gluconate intravenous and phenobarbital suppositories were administered for the seizures. However, serum Na level further decreased to 115 mmol/l. Intermittent seizures persisted even after administration of lidocaine, and there was no improvement in hyponatremia under water restriction. The diagnosis of SIADH was confirmed by the plasma ADH concentration (arginine vasopressin; AVP) of 3.6 pmol/l (3.9 pg/ml) and plasma concentration of atrial Na diuretic peptide (ANP) of 25.0 pmol/l (71.8 pg/ml), showing a high plasma ADH concentration in the presence of low serum osmolality (238 mmol/l) and elevated urinary osmolality (270 mmol/l). Fluid restriction (75 ml/kg/d) and intravenous administration of phenytoin (30 mg) were started. The seizures resolved immediately after administration, followed by an increase in urine volume (6 ml/kg/hr), body weight loss ( À142 g), and improvement of hyponatremia (128 mmol/l). The next day (22 days of age), serum and urinary osmolality and hyponatremia had improved, with urinary 
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osmolality 99 mmol/l, serum osmolality 252 mmol/l, and serum Na 135 mmol/l, and with no further occurrence of hyponatremia or convulsions ( Figure 1) . From immunostaining of a second biopsy at 13 days of age, nasal glial heterotopia of neurogenic congenital anomaly, rather than rhabdomyosarcoma, was diagnosed.
DISCUSSION
Phenytoin, administered for hyponatremia from SIADH caused by administration of anticancer drugs complicated with refractory seizure, caused immediate resolution of seizures and improved the symptoms of SIADH in a neonate. To our knowledge, this is the first reported case of effective therapeutic use of phenytoin for SIADH seizures in the neonatal period. Phenytoin inhibits calcium influx into the cells of the posterior pituitary and, thus, suppresses ADH secretion. Administration of phenytoin has been tried as SIADH treatment in adults and children. 4, 6, 7, 9 The present case manifested intractable seizures for which diazepam, lidocaine, and phenobarbital were ineffective, but they resolved immediately after administration of phenytoin, along with improvement of SIADH symptoms. Although there is a possibility that the combination of those anticonvulsants finally stopped the convulsions, the close temporal relationship between the start of phenytoin and the cessation of convulsions indicates that phenytoin was the main factor.
SIADH in the present case was triggered by the administration of anticancer drugs and, in addition, increased fluid input to alleviate possible renal damage. Cisplatin, vincristine, and cyclophosphamide are all known to cause SIADH in adult and older children.
2 SIADH is supposedly caused either by enhanced AVP secretion or enhancement of its effects on the distal nephron by anticancer drugs. 2 However, there have been almost very few reports on this issue in the neonatal period with only one report of SIADH in relation to vincristine administration in a neonate 3 weeks after birth. 10 In the neonatal period, renal concentrating capacity is limited, whereas diluting capacity is relatively developed. However, the capacity for increasing the urine volume is limited under water overloading, due to the low rate of glomerular filtration, resulting in a state of water intoxication. In the present case, precautions taken against possible renal damage by drugs appear to have resulted in fluid overloading, giving a warning when chemotherapy is administered in the neonatal period.
The mechanism by which phenytoin stopped the convulsive seizure should be discussed. It might work as an anticonvulsant. However, the time of cessation of the seizures, which coincided with the elevation of serum Na concentration, suggests that it might stop seizures by correcting the severe hyponatremia.
At present, phenytoin appears to be an effective treatment choice for hyponatremic seizures in SIADH, although its role remains to be defined from evaluation of more cases in the future.
